302 related articles for article (PubMed ID: 18358718)
1. Discovery of novel PRL-3 inhibitors based on the structure-based virtual screening.
Park H; Jung SK; Jeong DG; Ryu SE; Kim SJ
Bioorg Med Chem Lett; 2008 Apr; 18(7):2250-5. PubMed ID: 18358718
[TBL] [Abstract][Full Text] [Related]
2. Discovery of novel alpha-glucosidase inhibitors based on the virtual screening with the homology-modeled protein structure.
Park H; Hwang KY; Oh KH; Kim YH; Lee JY; Kim K
Bioorg Med Chem; 2008 Jan; 16(1):284-92. PubMed ID: 17920282
[TBL] [Abstract][Full Text] [Related]
3. Structure-based virtual screening approach to identify novel classes of Cdc25B phosphatase inhibitors.
Park H; Li M; Choi J; Cho H; Ham SW
Bioorg Med Chem Lett; 2009 Aug; 19(15):4372-5. PubMed ID: 19500977
[TBL] [Abstract][Full Text] [Related]
4. Structure-based virtual screening approach to identify novel classes of PTP1B inhibitors.
Park H; Bhattarai BR; Ham SW; Cho H
Eur J Med Chem; 2009 Aug; 44(8):3280-4. PubMed ID: 19269068
[TBL] [Abstract][Full Text] [Related]
5. Identification of novel inhibitors of extracellular signal-regulated kinase 2 based on the structure-based virtual screening.
Park H; Bahn YJ; Jeong DG; Woo EJ; Kwon JS; Ryu SE
Bioorg Med Chem Lett; 2008 Oct; 18(20):5372-6. PubMed ID: 18835158
[TBL] [Abstract][Full Text] [Related]
6. Discovery of novel Cdc25 phosphatase inhibitors with micromolar activity based on the structure-based virtual screening.
Park H; Bahn YJ; Jung SK; Jeong DG; Lee SH; Seo I; Yoon TS; Kim SJ; Ryu SE
J Med Chem; 2008 Sep; 51(18):5533-41. PubMed ID: 18714978
[TBL] [Abstract][Full Text] [Related]
7. Structure-based de novo design and biochemical evaluation of novel Cdc25 phosphatase inhibitors.
Park H; Bahn YJ; Ryu SE
Bioorg Med Chem Lett; 2009 Aug; 19(15):4330-4. PubMed ID: 19497739
[TBL] [Abstract][Full Text] [Related]
8. Structure-based virtual screening approach to the discovery of novel inhibitors of eyes absent 2 phosphatase with various metal chelating moieties.
Park H; Jung SK; Yu KR; Kim JH; Kim YS; Ko JH; Park BC; Kim SJ
Chem Biol Drug Des; 2011 Oct; 78(4):642-50. PubMed ID: 21777393
[TBL] [Abstract][Full Text] [Related]
9. A structure-based virtual screening approach toward the discovery of histone deacetylase inhibitors: identification of promising zinc-chelating groups.
Park H; Kim S; Kim YE; Lim SJ
ChemMedChem; 2010 Apr; 5(4):591-7. PubMed ID: 20157916
[TBL] [Abstract][Full Text] [Related]
10. Structure-based virtual screening approach to the discovery of novel inhibitors of factor-inhibiting HIF-1: identification of new chelating groups for the active-site ferrous ion.
Ko S; Lee MK; Shin D; Park H
Bioorg Med Chem; 2009 Nov; 17(22):7769-74. PubMed ID: 19822432
[TBL] [Abstract][Full Text] [Related]
11. Discovery of a potent, selective protein tyrosine phosphatase 1B inhibitor using a linked-fragment strategy.
Szczepankiewicz BG; Liu G; Hajduk PJ; Abad-Zapatero C; Pei Z; Xin Z; Lubben TH; Trevillyan JM; Stashko MA; Ballaron SJ; Liang H; Huang F; Hutchins CW; Fesik SW; Jirousek MR
J Am Chem Soc; 2003 Apr; 125(14):4087-96. PubMed ID: 12670229
[TBL] [Abstract][Full Text] [Related]
12. Structure-based virtual screening approach to the discovery of phosphoinositide 3-kinase alpha inhibitors.
Park H; Choi H; Hong S; Kim D; Oh DS; Hong S
Bioorg Med Chem Lett; 2011 Apr; 21(7):2021-4. PubMed ID: 21354792
[TBL] [Abstract][Full Text] [Related]
13. Structure-based virtual screening approach to the discovery of novel PTPMT1 phosphatase inhibitors.
Park H; Kim SY; Kyung A; Yoon TS; Ryu SE; Jeong DG
Bioorg Med Chem Lett; 2012 Jan; 22(2):1271-5. PubMed ID: 22115589
[TBL] [Abstract][Full Text] [Related]
14. Discovery of potent inhibitors of receptor protein tyrosine phosphatase sigma through the structure-based virtual screening.
Park H; Chien PN; Ryu SE
Bioorg Med Chem Lett; 2012 Oct; 22(20):6333-7. PubMed ID: 22989533
[TBL] [Abstract][Full Text] [Related]
15. Discovery and biological evaluation of novel alpha-glucosidase inhibitors with in vivo antidiabetic effect.
Park H; Hwang KY; Kim YH; Oh KH; Lee JY; Kim K
Bioorg Med Chem Lett; 2008 Jul; 18(13):3711-5. PubMed ID: 18524587
[TBL] [Abstract][Full Text] [Related]
16. A novel class of Hsp90 inhibitors isolated by structure-based virtual screening.
Park H; Kim YJ; Hahn JS
Bioorg Med Chem Lett; 2007 Nov; 17(22):6345-9. PubMed ID: 17869098
[TBL] [Abstract][Full Text] [Related]
17. Importance of molecular computer modeling in anticancer drug development.
Geromichalos GD
J BUON; 2007 Sep; 12 Suppl 1():S101-18. PubMed ID: 17935268
[TBL] [Abstract][Full Text] [Related]
18. Structure-based design of protein tyrosine phosphatase-1B inhibitors.
Black E; Breed J; Breeze AL; Embrey K; Garcia R; Gero TW; Godfrey L; Kenny PW; Morley AD; Minshull CA; Pannifer AD; Read J; Rees A; Russell DJ; Toader D; Tucker J
Bioorg Med Chem Lett; 2005 May; 15(10):2503-7. PubMed ID: 15863305
[TBL] [Abstract][Full Text] [Related]
19. Identification of potent VHZ phosphatase inhibitors with structure-based virtual screening.
Park H; Park SY; Oh JJ; Ryu SE
J Biomol Screen; 2013 Feb; 18(2):226-31. PubMed ID: 23042075
[TBL] [Abstract][Full Text] [Related]
20. Virtual screening and biochemical evaluation to identify new inhibitors of mammalian target of rapamycin (mTOR).
Park H; Choe H; Hong S
Bioorg Med Chem Lett; 2014 Feb; 24(3):835-8. PubMed ID: 24393580
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]